| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 02/11/2014 | CA2606471C Benzisoxazole piperidine compounds and methods of use thereof |
| 02/11/2014 | CA2536622C Inhibitors of cellular necrosis |
| 02/11/2014 | CA2511199C Small molecule modulators of hepatocyte growth factor (scatter factor) activity |
| 02/06/2014 | WO2014022343A1 7-hydroxy-indolinyl antagonists of p2y1 receptor |
| 02/06/2014 | WO2014021281A1 Partially saturated nitrogen-containing heterocyclic compound |
| 02/06/2014 | WO2014020458A1 Improved process for preparation of rivaroxaban |
| 02/06/2014 | WO2014020381A1 Novel crystalline form of azilsartan medoxomil potassium |
| 02/06/2014 | WO2014019967A1 N-cyclopropyl-n-piperidinyl-amides, pharmaceutical compositions containing them and uses thereof |
| 02/06/2014 | WO2014019951A1 Methods of controlling insects |
| 02/06/2014 | WO2013186792A3 Process for preparation of azilsartan medoxomil and its salts |
| 02/06/2014 | US20140039198 Pyrrole derivative and process for production thereof |
| 02/06/2014 | US20140039197 Processes for the preparation of 3,5-disubstituted-1,2,4-oxadiazoles |
| 02/06/2014 | US20140039183 Selective heterocyclic sphingosine 1 phosphate receptor modulators |
| 02/06/2014 | US20140039011 Macrocyclic urea and sulfamide derivatives as inhibitors of tafia |
| 02/06/2014 | US20140039009 Compounds for inflammation and immune-related uses |
| 02/06/2014 | US20140039007 Compositions and methods for modulating farnesoid x receptors |
| 02/06/2014 | US20140038993 New compounds |
| 02/06/2014 | US20140038979 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 02/06/2014 | US20140038975 Imidazole, Pyrazole, and Triazole Derivatives Useful As Antibacterial Agents |
| 02/06/2014 | US20140038965 5- and 6-membered heterocyclic compounds |
| 02/06/2014 | US20140038962 Flavivirus Inhibitors and Methods of Their Use |
| 02/06/2014 | US20140038960 Hetaryl-[1,8]naphthyridine derivatives |
| 02/06/2014 | US20140038958 Cdk8-cdk19 selective inhibitors and their use in anti-metastatic and chemopreventative methods for cancer |
| 02/06/2014 | US20140038947 Therapeutic applications of pro-apoptotic benzodiazepines |
| 02/06/2014 | US20140038943 Serotonin receptor modulator |
| 02/06/2014 | US20140038942 RORgammaT INHIBITORS |
| 02/06/2014 | US20140038938 Substituted dihydropyrazolones and their use |
| 02/06/2014 | US20140038937 Chromenone Derivatives |
| 02/06/2014 | US20140038919 Hepatitis c inhibitors and uses thereof |
| 02/06/2014 | US20140038821 Isoxazolines for controlling invertebrate pests |
| 02/05/2014 | EP2692727A2 Novel oxazolidinone derivative and medical composition containing same |
| 02/05/2014 | EP2691391A2 Compounds and methods for the treatment of isocitrate dehydrognase related diseases |
| 02/05/2014 | EP2691386A1 Quinoline derivatives as fungicides |
| 02/05/2014 | EP2691384A1 (alpha- substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5 -triazinyl benzimidazoles, pharmaceutical compositions containing them, and these compounds for use in treating proliferative diseases |
| 02/05/2014 | EP2691379A1 Herbicidally and fungicidally active 3-phenylisoxazoline-5-carboxamides and 3-phenylisoxazoline-5-thioamides |
| 02/05/2014 | EP2691375A1 Substituted benzimidazoles |
| 02/05/2014 | EP2691095A2 Imidazolyl amide compounds and uses related thereto |
| 02/05/2014 | CN103562204A Aminopyrazine compounds useful as inhibitors of TRA kinase |
| 02/05/2014 | CN103562191A Nitrogen-containing saturated heterocyclic compound |
| 02/05/2014 | CN103562190A Isoxazoline derivatives as antiparasitic agents |
| 02/05/2014 | CN103562185A Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 02/05/2014 | CN103554098A One group of 2-chlorine-3-pyridine formyl compounds |
| 02/05/2014 | CN103554095A Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 02/05/2014 | CN103554042A Triazole compounds that modulate hsp90 activity |
| 02/05/2014 | CN103554026A 3-trifluoromethyl-4-formyl pyrazole compounds |
| 02/05/2014 | CN103554006A Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease |
| 02/04/2014 | US8642808 Bis-aryl sulfonamides |
| 02/04/2014 | US8642774 Compounds |
| 02/04/2014 | US8642642 Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
| 02/04/2014 | US8642624 Substituted alkylamine derivatives and methods of use |
| 02/04/2014 | US8642611 Alkynylpyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same |
| 02/04/2014 | US8642609 Modulators of ATP-binding cassette transporters |
| 02/04/2014 | US8642595 Annellated 4-(indazolyl)-1,4-dihydropyridine derivatives and methods of use thereof |
| 02/04/2014 | US8642585 Indanyloxydihydrobenzofuranylacetic acids |
| 02/04/2014 | US8642025 Hepatitis C virus inhibitors |
| 02/04/2014 | CA2491191C Receptor-type kinase modulators and methods of use |
| 01/30/2014 | WO2014018807A1 Peptide epoxyketone compounds |
| 01/30/2014 | WO2014017569A1 Pharmaceutical product for lowering blood ldl |
| 01/30/2014 | WO2014017342A1 Indole derivative or pharmacologically acceptable salt thereof |
| 01/30/2014 | WO2014017093A1 Benzene ring-fused, nitrogen-containing 5-membered heterocyclic compound or pharmacologically acceptable salt thereof |
| 01/30/2014 | WO2014017045A1 Compound having acridan ring structure, and organic electroluminescent element |
| 01/30/2014 | WO2014016849A2 Novel triazine compounds |
| 01/30/2014 | WO2014016842A1 Amorphous coprecipitates of rivaroxaban |
| 01/30/2014 | WO2014016267A1 Benzisoxazole modulators of neurogenesis |
| 01/30/2014 | WO2014016191A1 N-cyclopropyl-n-piperidinyl-amide derivatives and their use as gpr119 modulators |
| 01/30/2014 | WO2013006734A8 Substituted 4-phenoxyphenol analogs as modulators of proliferating cell nuclear antigen activity |
| 01/30/2014 | US20140031402 Process for the Syntheses of Triazoles |
| 01/30/2014 | US20140031391 Novel 5-aminotetrahydroquinoline-2-carboxylic acids and their use |
| 01/30/2014 | US20140031378 Insecticidal spironindane derivatives |
| 01/30/2014 | US20140031374 Triazole derivatives as wnt signaling pathway inhibitors |
| 01/30/2014 | US20140031369 N-cyclopropyl-n-piperidinyl-amide derivatives, pharmaceutical compositions containing them and uses thereof |
| 01/30/2014 | US20140031364 Phenyl-isoxazol derivatives and preparation process thereof |
| 01/30/2014 | US20140031358 Quinazolinediones and their use |
| 01/30/2014 | US20140031353 Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof |
| 01/30/2014 | US20140031350 2,4-Pyrimidinediamine Compounds and Their Uses |
| 01/30/2014 | US20140031345 Quinazolines as potassium ion channel inhibitors |
| 01/30/2014 | US20140031339 Inhibitors of leukotriene production |
| 01/30/2014 | US20140031338 Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| 01/30/2014 | US20140031335 Cycloalkenyl aryl derivatives for cetp inhibitor |
| 01/30/2014 | US20140031334 Derivatives of 4-piperazin-1-yl-4-benzo[b]thiophene suitable for the treatment of cns disorders |
| 01/30/2014 | US20140031329 Substituted dihydropyrazolones for treating cardiovascular and hematological diseases |
| 01/30/2014 | US20140031317 Novel 2-substituted benzimidazoles as selective androgen receptor modulators (sarms) |
| 01/30/2014 | US20140031287 Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (glp-1) compound or a melanocortin-4 receptor (mic4) agonist peptide |
| 01/30/2014 | US20140030243 Anthranilamides compositions |
| 01/29/2014 | EP2690100A1 Process for making linezolid |
| 01/29/2014 | EP2688886A1 Azole compounds as pim inhibitors |
| 01/29/2014 | EP2688885A1 N-(1,3,4-oxadiazol-2-yl)arylcarboxamides and use thereof as herbicides |
| 01/29/2014 | EP2688881A1 New azaspirodecanone compounds as hsl inhibitors |
| 01/29/2014 | EP2688876A1 Isoxazoline derivatives as antiparasitic agents |
| 01/29/2014 | EP2688870A1 Heterocyclic amine derivatives |
| 01/29/2014 | EP2688866A1 Trpv1 antagonists |
| 01/29/2014 | EP2688648A1 A 5-ht4 receptor agonist as a prokinetic agent |
| 01/29/2014 | EP2418202B1 (4-[4-[5-(substituted amino)-pyridin-2-yl]phenyl]-cyclohexyl)-acetic acid derivatives as DGAT inhibitors |
| 01/29/2014 | EP2410857B1 P2x3, receptor antagonists for treatment of pain |
| 01/29/2014 | EP2394999B1 Aminopyrazine derivative and medicine |
| 01/29/2014 | CN1914224B HCV NS-3 serine protease inhibitors |
| 01/29/2014 | CN103547576A Parasiticidal dihydroisoxazole compounds |
| 01/29/2014 | CN103539791A Modulators of the GPR119 receptor and the treatment of disorders related thereto |
| 01/29/2014 | CN103539753A Synthesis method of high-regioselectivity 3-substituted-4-isoxazole carboxylic acid |
| 01/29/2014 | CN103539726A Novel compound with electron injection and/or electron transport capabilities and organic light-emitting device including the same |